3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid

C25H23ClN6O2 — CID 91231090

IUPAC3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid
SMILESCc1ccc(Nc2ncc(-c3cccc(C=CC(=O)O)c3)c(NCCc3cn[nH]c3)n2)cc1Cl
InChIInChI=1S/C25H23ClN6O2/c1-16-5-7-20(12-22(16)26)31-25-28-15-21(19-4-2-3-17(11-19)6-8-23(33)34)24(32-25)27-10-9-18-13-29-30-14-18/h2-8,11-15H,9-10H2,1H3,(H,29,30)(H,33,34)(H2,27,28,31,32)
InChIKeyBUTMFQMILIWHCT-UHFFFAOYSA-N
MW474.95 g/mol
LogP5.32
Rot. Bonds9

About 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid

3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid (PubChem CID 91231090) has the molecular formula C25H23ClN6O2 and a molecular weight of 474.95 g/mol. Its IUPAC name is 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid.

Molecular Properties

Compound Name3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid
PubChem CID91231090
Molecular FormulaC25H23ClN6O2
Molecular Weight474.95 g/mol
Exact Mass474.16
IUPAC Name3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid
SMILESCc1ccc(Nc2ncc(-c3cccc(C=CC(=O)O)c3)c(NCCc3cn[nH]c3)n2)cc1Cl
InChIInChI=1S/C25H23ClN6O2/c1-16-5-7-20(12-22(16)26)31-25-28-15-21(19-4-2-3-17(11-19)6-8-23(33)34)24(32-25)27-10-9-18-13-29-30-14-18/h2-8,11-15H,9-10H2,1H3,(H,29,30)(H,33,34)(H2,27,28,31,32)
InChIKeyBUTMFQMILIWHCT-UHFFFAOYSA-N
XLogP5.32
TPSA115.82 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500474.95
LogP ≤ 55.32
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid?
The IUPAC name of 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid (CID 91231090) is 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid.
What is the SMILES notation for 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid?
The canonical SMILES for 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid is Cc1ccc(Nc2ncc(-c3cccc(C=CC(=O)O)c3)c(NCCc3cn[nH]c3)n2)cc1Cl.
What is the InChIKey of 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid?
The InChIKey is BUTMFQMILIWHCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H23ClN6O2/c1-16-5-7-20(12-22(16)26)31-25-28-15-21(19-4-2-3-17(11-19)6-8-23(33)34)24(32-25)27-10-9-18-13-29-30-14-18/h2-8,11-15H,9-10H2,1H3,(H,29,30)(H,33,34)(H2,27,28,31,32).
What are the key properties of 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid?
3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid has a molecular weight of 474.95 g/mol, XLogP of 5.32, 9 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-[2-(3-chloro-4-methylanilino)-4-[2-(1H-pyrazol-4-yl)ethylamino]pyrimidin-5-yl]phenyl]prop-2-enoic acid is sourced from PubChem (CID 91231090), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).